Greystoke, Alastair
Steele, Nicola
Arkenau, Hendrik-Tobias
Blackhall, Fiona
Md Haris, Noor
Lindsay, Colin R
Califano, Raffaele
Voskoboynik, Mark
Summers, Yvonne
So, Karen
Ghiorghiu, Dana
Dymond, Angela W
Hossack, Stuart
Plummer, Ruth
Dean, Emma
Article History
Received: 23 December 2016
Revised: 26 May 2017
Accepted: 20 July 2017
First Online: 24 August 2017
Competing interests
: AG received consultancy fees from AstraZeneca. KS, DG and AWD are employees of AstraZeneca, and DG and AWD hold stock options. FB received a grant and personal fees from, and is a Board Member for AstraZeneca. NS has received travel costs from AstraZeneca for her attendance at AstraZeneca-funded meetings. RC, RP and YS have received honorarium for advisory boards from AstraZeneca. H-TA, NMD, CRL, SH and MV have no conflicts of interest to declare.